[Articles] Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial

Di |2024-04-11T00:30:01+02:00Aprile 11th, 2024|Categorie: Coronavirus Lancet|

The three dose groups of the candidate v7D vaccine exhibit similar humoral immunogenicity to the vOka vaccine and are well tolerated. These findings encourage further investigations on two-dose vaccination schedules, efficacy, and the potential safety ...

[Corrections] Correction to Lancet Infect Dis 2024; published online March 22. https://doi.org/10.1016/S1473-3099(24)00154-3

Di |2024-03-30T00:30:01+01:00Marzo 30th, 2024|Categorie: Coronavirus Lancet|

Dinkele R, Khan PY, Warner DF. Mycobacterium tuberculosis transmission: the importance of precision. Lancet Infect Dis 2024; published online March 22. https://doi.org/10.1016/S1473-3099(24)00154-3—In this Comment, the particle size of microscopic pauc...

[Corrections] Correction to Lancet Infect Dis 2024; published online Feb 1. https://doi.org/10.1016/S1473-3099(23)00706-5

Di |2024-03-28T00:30:06+01:00Marzo 28th, 2024|Categorie: Coronavirus Lancet|

Bertan M, D'Aeth JC, Abdullahi F, et al. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance stu...